Head of Medical Affairs at Nestlé Health Science
Vowst Maintains Consistent Safety Profile in rCDI Patients With Comorbidities
At MAD-ID, Dianne Nguyen, MD, shares Phase 3 data showing consistent tolerability of the microbiome therapy across high-risk patient populations
Read More